Feedback / Questions
Igalmi (dexmedetomidine sublingual) - BioXcel
https://www.globenewswire.com/news-release/2026/08/28/3352588/0/en/bioxcel-therapeutics-enters-into-asset-sale-agreement-with-teva-pharmaceuticals.html
Aug 28, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next